| 000 | 01341 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514070534.0 | ||
| 264 | 0 | _c20031015 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a1018-8665 | ||
| 024 | 7 |
_a10.1159/000069965 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDevos, S A | |
| 245 | 0 | 0 |
_aAdverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. _h[electronic resource] |
| 260 |
_bDermatology (Basel, Switzerland) _c2003 |
||
| 300 |
_a388-90 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aCrohn Disease _xcomplications |
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug Eruptions _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSteroids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVan Den Bossche, N | |
| 700 | 1 | _aDe Vos, M | |
| 700 | 1 | _aNaeyaert, J M | |
| 773 | 0 |
_tDermatology (Basel, Switzerland) _gvol. 206 _gno. 4 _gp. 388-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000069965 _zAvailable from publisher's website |
| 999 |
_c12557761 _d12557761 |
||